Skip to main content
Equibles

PRICE T ROWE ASSOCIATES INC /MD/

Position in FTRE — Fortrea Holdings Inc.

CIK 80255 BALTIMORE, MD
Back to FTRE Full portfolio

Position in FTRE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,642,172
+$1,475,798 QoQ
Shares Held
151,849
+22.6% QoQ
Ownership
0.160%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 334 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FTRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. FTRE ranks #146 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 2,678,047 $2,484,611,664
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,529,709 $953,834,749
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,728,421 $858,558,562
4 KYMR
Kymera Therapeutics, Inc.
 7,112,980 $815,645,416
5 RPRX
Royalty Pharma plc
 11,193,657 $627,628,347
6 RVMD
Revolution Medicines, Inc.
 2,969,853 $447,655,945
7 MRNA
Moderna, Inc.
 5,589,560 $391,436,886
8 TWST
Twist Bioscience Corp
 3,634,652 $373,932,997

All Filings in FTRE

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,642,172 151,849
2026-03-31 $1,166,374 123,819
2025-12-31 $1,948,974 112,984
2025-09-30 $778,597 92,470
2025-06-30 $391,055 79,161
2025-03-31 $494,426 65,487
2024-12-31 $1,112,099 59,630
2024-09-30 $1,107,400 55,370
2024-06-30 $1,224,066 52,445
2024-03-31 $2,028,314 50,531
2023-12-31 $1,668,220 47,800
2023-09-30 $1,316,712 46,055